A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
Christina Giannakou,1,2 Margriet VDZ Park,1 Wim H de Jong,1 Henk van Loveren,1,2 Rob J Vandebriel,1 Robert E Geertsma1 1Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, 2Department of Toxicogenomics, Maastricht University, Maastricht...
Guardado en:
Autores principales: | Giannakou C, Park MV, de Jong WH, van Loveren H, Vandebriel RJ, Geertsma RE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/493e28286387461b99d83869c77d6d7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanomedicinal products: a survey on specific toxicity and side effects
por: Brand W, et al.
Publicado: (2017) -
Microcystin-Induced Immunotoxicity in Fishes: A Scoping Review
por: Wang Lin, et al.
Publicado: (2021) -
Systemic and immunotoxicity of pristine and PEGylated multi-walled carbon nanotubes in an intravenous 28 days repeated dose toxicity study
por: Zhang T, et al.
Publicado: (2017) - Nanomedicine journal
- Journal of Interdisciplinary nanomedicine